Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Open Offer Result - Amendment

3 Nov 2006 13:17

Stanelco PLC03 November 2006 NOT FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN. The following replaces the Open Offer Result announcement released on 2 November2006 at 18.03 under RNS number 4953L. In paragraph 3 the balance of Open Offer Shares, which have been allocated tothe institutional investors with whom they had been conditionally placed, shouldread "139,122,726" and not "139,121,895". The full amended text appears below. OPEN OFFER RESULT 2 November 2006 Stanelco plc ("Stanelco" or the "Company") On 9 October 2006, Stanelco announced details of a proposed Firm Placing of1,375,000,000 New Ordinary Shares and Open Offer of 600,992,559 New OrdinaryShares at 0.8 pence per New Ordinary Share, of which 148,278,000 New OrdinaryShares were being placed subject to clawback to satisfy valid acceptances underthe Open Offer. The Open Offer has now closed in accordance with its terms. The Board ofStanelco announces that valid acceptances under the Open Offer have beenreceived from Qualifying Shareholders in respect of 461,869,833 Open OfferShares. This represents approximately 76.85 per cent. of the Open Offer Sharesoffered pursuant to the Open Offer. As a result of the acceptances received under the Open Offer, the balance of139,122,726 Open Offer Shares, representing 93.83 per cent. of the 148,278,000New Ordinary Shares placed subject to clawback, have been allocated to theinstitutional investors with whom they had been conditionally placed. The Firm Placing, Placing and Open Offer remain conditional upon the passing ofthe Resolutions at the Extraordinary General Meeting to be held at 11.00am on 6November 2006 and upon Admission. The final time and date for receipt of Forms of Proxy in relation to theExtraordinary General Meeting is 11.00 a.m. on 4 November 2006. Completion andreturn of a Form of Proxy will not preclude Shareholders from attending andvoting in person at the Extraordinary General Meeting. It is expected that Admission will occur no later than 8.00 a.m. on 7 November 2006 or such later date as Teather & Greenwood Limited and Stanelco may agree. For further information please contact: Stanelco plcMartin Wagner, Chief ExecutiveSylvia Leavey, Investor RelationsTel: 44 (0) 2380 867 100 Press: Financial DynamicsJonathon Brill/Billy CleggTel: 44 (0) 20 7831 3113 This announcement is for information only and does not constitute an offer orinvitation to acquire or dispose of any securities or investment advice in anyjurisdiction. Past performance is no guide to future performance and persons needing adviceshould consult an independent financial advisor. The information contained in this announcement is not for release, publicationor distribution, directly or indirectly, to persons in the United States,Canada, Australia, Japan or the Republic of South Africa. This announcement isnot an offer of securities for sale into the United States. The New OrdinaryShares have not and will not be registered under the US Securities Act of 1933,as amended and may not be offered or sold directly or indirectly, in the UnitedStates absent registration or an exemption from registration. There will be nopublic offering of securities in the United States. The New Ordinary Shares havenot and will not be registered with any regulatory authority of any state withinthe United States. Teather & Greenwood Limited, which is authorised and regulated in the UnitedKingdom by the Financial Services Authority, is acting exclusively for theCompany as sponsor, financial adviser and stockbroker in relation to the Issueand no-one else in connection with the arrangements described in thisannouncement and will not be responsible to anyone other than the Company forproviding the protections afforded to customers of Teather & Greenwood or for advising any other person in connection with the arrangements described in thisannouncement. This announcement has been issued by Stanelco and is the sole responsibility ofStanelco. Defined terms used in this announcement are as used in the prospectus ofStanelco dated 12 October 2006, which may be inspected at the UKLA's documentviewing facility situated at the Financial Services Authority, 25 The NorthColonnade, Canary Wharf, London E14 5HS This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.